间皮瘤临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 间皮瘤（国际通用名 mesothelioma）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。

正在招募的间皮瘤新药试验

• Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

  I 期 / II 期招募中BelgiumNCT05765084

• Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

  不适用招募中NorwayNCT02073500

• A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  I 期招募中美国NCT07705334

• 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

  II 期招募中美国NCT06503146

• TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

  I 期 / II 期招募中美国NCT04969315

• Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)

  不适用招募中意大利NCT06637345

• Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  I 期 / II 期招募中美国法国西班牙NCT05732831

• Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

  不适用招募中法国NCT06907095

• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  I 期招募中美国NCT05245500

• A Study of NX-1607 in Adults With Advanced Malignancies

  I 期招募中美国英国NCT05107674

• GPC3/Mesothelin-CAR-γδT Cells Against Cancers

  I 期招募中中国NCT06196294

• Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

  不适用招募中BelgiumNCT01617382